We offer a high-throughput screening (HTS) platform that allows for the rapid testing of large chemical libraries against various fungal pathogens. This service is ideal for pharmaceutical companies, academic institutions, and biotechnology firms seeking to discover novel antifungal compounds. Our approach is flexible, allowing us to screen for compounds with different mechanisms of action, including those targeting essential cellular processes or disrupting cell wall and membrane integrity.
Our service package is customizable to fit your specific research needs.
Turnaround Time
The turnaround time for our services varies depending on the scope of the project, including the size of the compound library and the complexity of the assays. A typical primary screen of 100,000 compounds can be completed in approximately 4-8 weeks from the start of the project. A detailed timeline will be provided after the initial consultation.
Antifungal resistance is a growing global health threat. Existing drugs often have side effects or limited efficacy; discovering new drug classes is a top priority. Traditional screening methods are slow and labor-intensive. Our HTS platform addresses this need by dramatically increasing the speed and efficiency of the drug discovery process, enabling the testing of millions of compounds in a fraction of the time. This helps to overcome the bottleneck in early-stage drug discovery and accelerates the identification of lead compounds.
Understanding a compound's mechanism of action is crucial for its development. We don't just identify hits; we help you understand how they work. Our services include:
